Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0893 in Type 2 Diabetes Mellitus
NCT02004886Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2006
- Primary completion
- Feb 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MK-0893 in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Aug 2006; status: completed.
02
Drugs
MK-0893
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02004886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02004886.